1
|
Shohet J and Foster J: Neuroblastoma. BMJ.
357:j18632017. View Article : Google Scholar : PubMed/NCBI
|
2
|
Abo-Elenain A, Naiem Y, Hamedhosam-Eldin
Hotmail Com H, Emam M, Elkashef W and AbdelRafee A: Right adrenal
gland neuroblastoma infiltrating the liver and mimicking
mesenchymal hamartoma: A case report. Int J Surg Case Rep.
12:95–98. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Park JR, Eggert A and Caron H:
Neuroblastoma: Biology, prognosis, and treatment. Pediatr Clin
North Am. 5597–120. (x)2008. View Article : Google Scholar : PubMed/NCBI
|
4
|
Castleberry RP, Shuster JJ and Smith EI:
The Pediatric Oncology Group experience with the international
staging system criteria for neuroblastoma. Member Institutions of
the Pediatric Oncology Group. J Clin Oncol. 12:2378–2381. 1994.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Tonini GP: Growth, progression and
chromosome instability of Neuroblastoma: A new scenario of
tumorigenesis? BMC Cancer. 17:202017. View Article : Google Scholar : PubMed/NCBI
|
6
|
Galli S, Naranjo A, Van Ryn C, Tilan JU,
Trinh E, Yang C, Tsuei J, Hong SH, Wang H, Izycka-Swieszewska E, et
al: Neuropeptide Y as a biomarker and therapeutic target for
neuroblastoma. Am J Pathol. 186:3040–3053. 2016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Lee SG, Jeon HY, Su ZZ, Richards JE,
Vozhilla N, Sarkar D, Van Maerken T and Fisher PB: Astrocyte
elevated gene-1 contributes to the pathogenesis of neuroblastoma.
Oncogene. 28:2476–2484. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Brunen D, de Vries RC, Lieftink C,
Beijersbergen RL and Bernards R: PIM kinases are a potential
prognostic biomarker and therapeutic target in neuroblastoma. Mol
Cancer Ther. 17:849–857. 2018. View Article : Google Scholar : PubMed/NCBI
|
9
|
Galinski B, Luxemburg M, Ewart M,
Landesman Y and Weiser D: Abstract 1938: Exportin-1 (XPO1) is a
novel therapeutic biomarker for patients with neuroblastoma. Cancer
Res. 77:1938. 2017.
|
10
|
Cui X, Yang Y, Jia D, Jing Y, Zhang S,
Zheng S, Cui L, Dong R and Dong K: Downregulation of bone
morphogenetic protein receptor 2 promotes the development of
neuroblastoma. Biochem Biophys Res Commun. 483:609–616. 2017.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Ishizuka Y, Koshinaga T, Hirano T,
Nagasaki-Maeoka E, Watanabe Y, Hoshi R, Yoshizawa S, Sugito K,
Kawashima H, Uekusa S, et al: NRP1 knockdown promotes the migration
and invasion of human neuroblastoma-derived SKNAS cells via the
activation of β1 integrin expression. Int J Oncol. 53:159–166.
2018.PubMed/NCBI
|
12
|
Mei Z, Yan P, Wang Y, Liu S and He F:
Knockdown of zinc transporter ZIP8 expression inhibits
neuroblastoma progression and metastasis in vitro. Mol Med Rep.
18:477–485. 2018.PubMed/NCBI
|
13
|
Irshad S, Pedley RB, Anderson J, Latchman
DS and Budhram-Mahadeo V: The Brn-3b transcription factor regulates
the growth, behavior and invasiveness of human neuroblastoma cells
in vitro and in vivo. J Biol Chem. 290:21617–21627. 2015.
View Article : Google Scholar
|
14
|
Souzaki R, Tajiri T, Souzaki M, Kinoshita
Y, Tanaka S, Kohashi K, Oda Y, Katano M and Taguchi T: Hedgehog
signaling pathway in neuroblastoma differentiation. J Pediatr Surg.
45:2299–2304. 2010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Hart LS, Rader J, Raman P, Batra V,
Russell MR, Tsang M, Gagliardi M, Chen L, Martinez D, Li Y, et al:
Preclinical therapeutic synergy of MEK1/2 and CDK4/6 inhibition in
neuroblastoma. Clin Cancer Res. 23:1785–1796. 2017. View Article : Google Scholar : PubMed/NCBI
|
16
|
Carvalho BS and Irizarry RA: A framework
for oligonucleotide microarray preprocessing. Bioinformatics.
26:2363–2367. 2010. View Article : Google Scholar : PubMed/NCBI
|
17
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
18
|
Smyth GK, Ritchie M, Thorne N and
Wettenhall J: LIMMA: Linear models for microarray data. In:
Bioinformatics and Computational Biology Solutions Using R and
BioconductorSBH; 2005
|
19
|
Hulsegge I, Kommadath A and Smits MA:
Globaltest and GOEAST: Two different approaches for Gene Ontology
analysis. BMC Proc. 3 (Suppl 4):S102009. View Article : Google Scholar : PubMed/NCBI
|
20
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
21
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization, and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Szklarczyk D, Franceschini A, Kuhn M,
Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork
P, et al: The STRING database in 2011: Functional interaction
networks of proteins, globally integrated and scored. Nucleic Acids
Res 39 (Database Issue). D561–D568. 2011. View Article : Google Scholar
|
23
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
24
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
25
|
Han H, Shim H, Shin D, Shim JE, Ko Y, Shin
J, Kim H, Cho A, Kim E, Lee T, et al: TRRUST: A reference database
of human transcriptional regulatory interactions. Sci Rep.
5:114322015. View Article : Google Scholar : PubMed/NCBI
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Norabuena E: Characterization of a human
neuroblastoma cell line and its differentiation into dopamine
neurons (unpublished PhD thesis)Mount Holyoke College; 2012
|
28
|
Candito M, Thyss A, Albertini M, Deville
A, Politano S, Mariani R and Chambon P: Methylated catecholamine
metabolites for diagnosis of neuroblastoma. Med Pediatr Oncol.
20:215–220. 1992. View Article : Google Scholar : PubMed/NCBI
|
29
|
Bozzi F, Luksch R, Collini P, Gambirasio
F, Barzanò E, Polastri D, Podda M, Brando B and Fossati-Bellani F:
Molecular detection of dopamine decarboxylase expression by means
of reverse transcriptase and polymerase chain reaction in bone
marrow and peripheral blood: Utility as a tumor marker for
neuroblastoma. Diagn Mol Pathol. 13:135–143. 2004. View Article : Google Scholar : PubMed/NCBI
|
30
|
Lo Vasco VR: 1p36.32 rearrangements and
the role of PI-PLC η2 in nervous tumours. J Neurooncol.
103:409–416. 2011. View Article : Google Scholar : PubMed/NCBI
|
31
|
Zhou Y, Wing MR, Sondek J and Harden TK:
Molecular cloning and characterization of PLC-eta2. Biochem J.
391:667–676. 2005. View Article : Google Scholar : PubMed/NCBI
|
32
|
Modarressi MH, Taylor KE and Wolfe J:
Cloning, characterization, and mapping of the gene encoding the
human G protein gamma 2 subunit. Biochem Biophys Res Commun.
272:610–615. 2000. View Article : Google Scholar : PubMed/NCBI
|
33
|
Shuba YM, Teslenko VI, Savchenko AN and
Pogorelaya NH: The effect of permeant ions on single calcium
channel activation in mouse neuroblastoma cells: Ion-channel
interaction. J Physiol. 443:25–44. 1991. View Article : Google Scholar : PubMed/NCBI
|
34
|
Barton AC and Sibley DR: Agonist-induced
desensitization of D1-dopamine receptors linked to adenylyl cyclase
activity in cultured NS20Y neuroblastoma cells. Mol Pharmacol.
38:531–541. 1990.PubMed/NCBI
|
35
|
Fukunaga K and Miyamoto E: Role of MAP
kinase in neurons. Mol Neurobiol. 16:79–95. 1998. View Article : Google Scholar : PubMed/NCBI
|
36
|
Morón JA, Zakharova I, Ferrer JV, Merrill
GA, Hope B, Lafer EM, Lin ZC, Wang JB, Javitch JA, Galli A and
Shippenberg TS: Mitogen-activated protein kinase regulates dopamine
transporter surface expression and dopamine transport apacity. J
Neurosci. 23:8480–8488. 2003. View Article : Google Scholar : PubMed/NCBI
|
37
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
38
|
Ries V, Silva RM, Oo TF, Cheng HC,
Rzhetskaya M, Kholodilov N, Flavell RA, Kuan CY, Rakic P and Burke
RE: JNK2 and JNK3 combined are essential for apoptosis in dopamine
neurons of the substantia nigra, but are not required for axon
degeneration. J Neurochem. 107:1578–1588. 2008. View Article : Google Scholar : PubMed/NCBI
|
39
|
Herdman ML, Marcelo A, Ying H, Niles RM,
Dhar S and Kiningham KK: Thimerosal Induces Apoptosis in a
Neuroblastoma Model via the cJun N-terminal kinase pathway. Toxicol
Sci. 92:246–253. 2006. View Article : Google Scholar : PubMed/NCBI
|
40
|
Uribe V: The beta-tubulin gene TUBB2B is
involved in a large spectrum of neuronal migration disorders. Clin
Genet. 77:34–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
41
|
Xu Y, Xu C, Kato A, Tempel W, Abreu JG,
Bian C, Hu Y, Hu D, Zhao B, Cerovina T, et al: Tet3 CXXC domain and
dioxygenase activity cooperatively regulate key genes for xenopus
eye and neural development. Cell. 151:1200–1213. 2012. View Article : Google Scholar : PubMed/NCBI
|
42
|
Chang SH, Jung IS, Han GY, Kim NH, Kim HJ
and Kim CW: Proteomic profiling of brain cortex tissues in a Tau
transgenic mouse model of Alzheimer's disease. Biochem Biophys Res
Commun. 430:670–675. 2013. View Article : Google Scholar : PubMed/NCBI
|
43
|
Pope WB, Lambert MP, Leypold B, Seupaul R,
Sletten L, Krafft G and Klein WL: Microtubule-associated protein
tau is hyperphosphorylated during mitosis in the human
neuroblastoma cell line SH-SY5Y. Exp Neurol. 126:185–194. 1994.
View Article : Google Scholar : PubMed/NCBI
|
44
|
Lorkowski S: RASL11B (RAS-like, family 11,
member B). Atlas Genet Cytogenet Oncol Haematol. 14:747–750.
2010.
|
45
|
Stolle K, Schnoor M, Fuellen G, Spitzer M,
Cullen P and Lorkowski S: Cloning, genomic organization, and
tissue-specific expression of the RASL11B gene. Biochim Biophys
Acta. 1769:514–524. 2007. View Article : Google Scholar : PubMed/NCBI
|
46
|
Ke XX, Zhang D, Zhao H, Hu R, Dong Z, Yang
R, Zhu S, Xia Q, Ding HF and Cui H: Phox2B correlates with MYCN and
is a prognostic marker for neuroblastoma development. Oncol Lett.
9:2507–2514. 2015. View Article : Google Scholar : PubMed/NCBI
|
47
|
Bachetti T, Di Paolo D, Di Lascio S,
Mirisola V, Brignole C, Bellotti M, Caffa I, Ferraris C, Fiore M,
Fornasari D, et al: PHOX2B-mediated regulation of ALK expression:
In vitro identification of a functional relationship between two
genes involved in neuroblastoma. PLoS One. 5(pii): e131082010.
View Article : Google Scholar : PubMed/NCBI
|
48
|
Desgrosellier JS and Cheresh DA: Integrins
in cancer: Biological implications and therapeutic opportunities.
Nat Rev Cancer. 10:9–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
49
|
Judware R and Culp LA: Concomitant
down-regulation of expression of integrin subunits by N-myc in
human neuroblastoma cells: Differential regulation of alpha2,
alpha3 and beta1. Oncogene. 14:1341–1350. 1997. View Article : Google Scholar : PubMed/NCBI
|
50
|
Peng H, Ke XX, Hu R, Yang L, Cui H and Wei
Y: Essential role of GATA3 in regulation of differentiation and
cell proliferation in SK-N-SH neuroblastoma cells. Mol Med Rep.
11:881–886. 2015. View Article : Google Scholar : PubMed/NCBI
|
51
|
Fischer I, Shea TB, Sapirstein VS and
Kosik KS: Expression and distribution of microtubule-associated
protein 2 (MAP2) in neuroblastoma and primary neuronal cells. Brain
Res. 25:99–109. 1986. View Article : Google Scholar
|
52
|
Braekeveldt N, Wigerup C, Gisselsson D,
Mohlin S, Merselius M, Beckman S, Jonson T, Börjesson A, Backman T,
Tadeo I, et al: Neuroblastoma patient-derived orthotopic xenografts
retain metastatic patterns and geno- and phenotypes of patient
tumours. Int J Cancer. 136:E252–E261. 2015. View Article : Google Scholar : PubMed/NCBI
|
53
|
Brodeur GM: Neuroblastoma: Biological
insights into a clinical enigma. Nat Rev Cancer. 3:203–216. 2003.
View Article : Google Scholar : PubMed/NCBI
|